A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2004
08/19/2004	DE20220917U1 Zusammensetzungen zur Verhinderung des Missbrauchs von Opioiden Compositions to prevent the misuse of opioids
08/19/2004	DE202004007363U1 Quarkpackung Quark pack
08/19/2004	DE19782131B4 Halteeinrichtungen und Verfahren zum Positionieren mehrerer Objekte auf einem Substrat Holding devices and methods for positioning multiple objects on a substrate
08/19/2004	DE19734544B4 Schellackhaltiges kosmetisches Produkt und Verfahren zu dessen Herstellung Shellac-containing cosmetic product and process for its preparation
08/19/2004	DE10310825B3 Unit releasing pharmaceutical substances under remote control, includes cavity with magnetic rotor turned by magnetic field to generate heat through friction
08/19/2004	DE10305318A1 Treating bacterial infections of respiratory organs comprises local administration of ciprofloxacin, enrofloxacin or their sparingly soluble salts in solid form
08/19/2004	CA2694872A1 Improved thickened beverages for dysphagia
08/19/2004	CA2515025A1 Sugar-free oral transmucosal solid dosage forms and uses thereof
08/19/2004	CA2514968A1 Pharmaceutical compositions comprising an active agent and chitosan for sustained drug release or mucoadhesion
08/19/2004	CA2514571A1 Wireless medical data communication system and method
08/19/2004	CA2514294A1 Medical data communication notification and messaging system and method
08/19/2004	CA2514273A1 Novel fluticasone formulations
08/19/2004	CA2513687A1 System and method for verifying medical device operational parameters
08/19/2004	CA2513649A1 Method and system for medical device connectivity
08/19/2004	CA2513402A1 Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
08/19/2004	CA2513260A1 Oral compositions of fenretinide having increased bioavailability and methods of using the same
08/19/2004	CA2509958A1 Pharmaceutical formulation
08/18/2004	EP1447343A2 Injection moulded water-soluble container
08/18/2004	EP1447145A2 Member provided with a surface layer of adsorbed functional particles
08/18/2004	EP1447101A1 Process for producing sterile pharmaceutical compounds
08/18/2004	EP1447097A1 Percutaneous absorption type medicinal preparation
08/18/2004	EP1447094A1 Remedies for pruritus
08/18/2004	EP1447086A1 An aqueous metal bicarbonate solution and method of use
08/18/2004	EP1447084A1 Freeze-dried pharmaceutical preparation
08/18/2004	EP1447082A1 Non-;gelatinous capsule film compositions and capsules using the same
08/18/2004	EP1447081A1 Sugar-modified liposome and products comprising the liposome
08/18/2004	EP1447080A1 Method for producing virosome-like particles
08/18/2004	EP1447079A1 Vesicles with chimeric receptors to induce a targeted T-cell response in vivo
08/18/2004	EP1447012A1 Nutritional supplement to treat macular degeneration
08/18/2004	EP1446659A2 Systems and methods for the generation of crystalline polymorphs
08/18/2004	EP1446504A2 Emulsion compositions
08/18/2004	EP1446423A2 Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders
08/18/2004	EP1446176A1 Microneedle transdermal transport device
08/18/2004	EP1446168A1 Medical dressings
08/18/2004	EP1446167A2 Treating canker sores with patches to speed healing and relieve pain
08/18/2004	EP1446140A2 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi)
08/18/2004	EP1446138A2 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)
08/18/2004	EP1446126A1 Coated particulate cefuroxime axetil compositions
08/18/2004	EP1446119A2 Compositions comprising ipatropium and xylometazoline for treatment of the common cold
08/18/2004	EP1446118A1 Oral dosage form of a sulfonamide prodrug such as parecoxib
08/18/2004	EP1446109A1 Methods and compositions for use of (s)-bisoprolol
08/18/2004	EP1446107A1 Process for the preparation of tablets comprising s-adenosylmethionine
08/18/2004	EP1446106A2 Optimal polymer mixtures for gastric retentive tablets
08/18/2004	EP1446105A1 Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods
08/18/2004	EP1446104A1 Spray drying methods and compositions thereof
08/18/2004	EP1446103A2 Injectable compositions for the controlled delivery of pharmacologically active compound
08/18/2004	EP1446102A1 Delivery of caffeine through an inhalation route
08/18/2004	EP1446101A2 Catheter injectable depot compositions and uses thereof
08/18/2004	EP1446100A2 Injectable depot compositions and uses thereof
08/18/2004	EP1446099A1 Injectable depot composition
08/18/2004	EP1446096A1 Topical compositions containing enzymes stabilised with inhibitors
08/18/2004	EP1446093A1 Potentiated topical composition
08/18/2004	EP1446088A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
08/18/2004	EP1446087A2 Method for treating non-neuropathic pain
08/18/2004	EP1446086A1 Compositions containing oils having a specific gravity higher than the specific gravity of water
08/18/2004	EP1446045A2 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
08/18/2004	EP1446010A2 Stabilized azithromycin compositions
08/18/2004	EP1446008A2 Compositions and methods for controlled release
08/18/2004	EP1345585A4 Compositions for prevention and alleviation of skin wrinkles
08/18/2004	EP1294479B1 Method for producing capsules containing an active ingredient and having an ultra-thin coating
08/18/2004	EP1232100B1 Injection-moulded water-soluble container
08/18/2004	EP1202713B1 Artificial tear replacement solution
08/18/2004	EP1194109B1 Topical formulations comprising skin penetration agents and the use thereof
08/18/2004	EP1187611B1 Ophthalmic histamine compositions and uses thereof
08/18/2004	EP1178833B1 Topical compositions for prostaglandin e 1 delivery
08/18/2004	EP1152744B1 Skin sanitizing compositions
08/18/2004	EP1117390B1 Mucosal originated drug delivery systems
08/18/2004	EP1094841B1 Pharmaceutical levothyroxine preparation
08/18/2004	EP1083882A4 A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier
08/18/2004	EP1079803B1 Protein formulations
08/18/2004	EP1045637A4 Decorated red blood cells
08/18/2004	EP1021155B1 Water dispersible perfluoroether polymer encapsulates
08/18/2004	EP1011610A4 Skin care compositions and use
08/18/2004	EP1004296B1 Powder containing fat-soluble drug
08/18/2004	EP0946621B1 Cationic film-forming polymer compositions containing same, and uses thereof, including topical delivery system and method of delivering agents to the skin and hair
08/18/2004	EP0928135A4 System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment
08/18/2004	EP0881899B1 Dosage form of ibuprofen
08/18/2004	EP0835137B1 Encapsulated cells producing viral particles
08/18/2004	EP0784490B1 Differentially biodegradable biomedical implants
08/18/2004	EP0767655B1 Methods of treating hypertension
08/18/2004	CN2633287Y Medicinal nasal obstruction
08/18/2004	CN1522286A System for releasing active substances and active agents
08/18/2004	CN1522256A Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine
08/18/2004	CN1522159A Interferon formulations
08/18/2004	CN1522158A Treatment of parasitic disease
08/18/2004	CN1522154A Vaccines including as an adjuvant type 1 IFN and process related thereto
08/18/2004	CN1522153A Novel composition
08/18/2004	CN1522150A Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue
08/18/2004	CN1522149A Promoting whole body health
08/18/2004	CN1522145A Compositions and methods for treating vulvovaginitis and vaginosis
08/18/2004	CN1522141A Soft capsules
08/18/2004	CN1522140A Oxcarbazepine dosage forms
08/18/2004	CN1522139A Enhanced parmacokinetic profile of hydrophobic substances
08/18/2004	CN1522132A Composition for freshening nostrils and sinus cavities
08/18/2004	CN1521179A Chickweed total flavones , their production method , use and preparation containing the same
08/18/2004	CN1520897A Electronic physical therapy plaster
08/18/2004	CN1520895A Sustained delivery of an active agent using an implantable system
08/18/2004	CN1520879A Chinese caterpillar fungus ginseng dan drop pills and preparing process thereof
08/18/2004	CN1520871A Effervescence granulas for treating gynecologic inflammations and preparing process thereof
08/18/2004	CN1520866A Traditional Chinese medicine compound ointment for children dermatosis

1 ... 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 ... 2991